Washington D.C.’s medical marijuana market hit a new milestone in April, with licensed dispensaries generating $5,456,393 in sales—the highest monthly total since the program launched in 2013.
The record-setting figure marks a sharp increase from the $3.67 million sold in March and nearly doubles the $2.87 million recorded in April 2024. In total, dispensaries brought in nearly $15 million during the first four months of 2025.
The jump in revenue comes as patient participation continues to climb. More than 33,000 patients made purchases from a licensed dispensary in April, including over 16,000 D.C. residents, nearly 14,000 self-certified out-of-state patients, and more than 3,000 reciprocity patients.
Flower remains the top-selling category, accounting for over $2.9 million in sales, followed by vape cartridges at nearly $950,000. Edibles, pre-rolls, tinctures, and infused topicals also saw substantial gains.
While overall sales volume is up, the average transaction size declined slightly, with in-store purchases averaging $67 among D.C. residents in April—down from $71 in March.
April’s figures confirm that 2025 is shaping up to be a record-breaking year for Washington D.C.’s medical marijuana program, with patient access and product availability continuing to expand.
For a full report of D.C.’s medical cannabis sales in 2024 and 2025, click here.
